Cargando…

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

Cancer stemness, referring to the stem-cell-like phenotype of cancer cells, has been recognised to play important roles in different aspects of hepatocarcinogenesis. A number of well-established cell-surface markers already exist for liver cancer stem cells, with potential new markers of liver cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsui, Yu-Man, Chan, Lo-Kong, Ng, Irene Oi-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217836/ https://www.ncbi.nlm.nih.gov/pubmed/32231294 http://dx.doi.org/10.1038/s41416-020-0823-9

Ejemplares similares

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma
por: Chan, Lo-Kong, et al.
Publicado: (2015)

Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma
por: Tsui, Yu-Man, et al.
Publicado: (2017)

Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma – an immunohistochemical study
por: Lo, Regina Cheuk-lam, et al.
Publicado: (2017)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2022)

Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
por: Huang, Hongyang, et al.
Publicado: (2023)

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2021)

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020)

Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
por: Lo, Regina Cheuk-Lam, et al.
Publicado: (2018)

Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling
por: Leung, Carmen Oi-Ning, et al.
Publicado: (2016)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
por: Kam, Charles Shing, et al.
Publicado: (2023)

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1
por: Zhang, Vanilla Xin, et al.
Publicado: (2021)

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma
por: Tian, Lu, et al.
Publicado: (2021)

Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?
por: Zhang, Qing-yang, et al.
Publicado: (2022)

Molecular genetic study in hepatocellular carcinoma: microRNA deregulation in multistep hepatocarcinogenesis
por: Ng, Irene Oi-Lin
Publicado: (2012)

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma
por: Kai, Alan Ka‐Lun, et al.
Publicado: (2016)

RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
por: Wang, Xia, et al.
Publicado: (2021)

Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
por: Wong, Carmen Chak-Lui, et al.
Publicado: (2008)

RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma
por: Ma, Wei, et al.
Publicado: (2016)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation
por: Fang, Xiaona, et al.
Publicado: (2022)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma
por: Leung, Carmen Oi-ning, et al.
Publicado: (2015)

Cancer stem cells of hepatocellular carcinoma
por: Wang, Kewei, et al.
Publicado: (2018)

The Cancer Stem Cell in Hepatocellular Carcinoma
por: Schulte, Lucas-Alexander, et al.
Publicado: (2020)

Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular Cancer
por: Kogure, Takayuki, et al.
Publicado: (2013)

SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop
por: Cui, Chun-Ping, et al.
Publicado: (2017)

Nuclear-Targeted Deleted in Liver Cancer 1 (DLC1) Is Less Efficient in Exerting Its Tumor Suppressive Activity Both In Vitro and In Vivo
por: Chan, Lo-Kong, et al.
Publicado: (2011)

UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
por: Ying, Fan, et al.
Publicado: (2023)

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Deleted in Liver Cancer 1 (DLC1) Utilizes a Novel Binding Site for Tensin2 PTB Domain Interaction and Is Required for Tumor-Suppressive Function
por: Chan, Lo-Kong, et al.
Publicado: (2009)

The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma
por: Chin, King-Tung, et al.
Publicado: (2005)

Novel molecular targets in hepatocellular carcinoma
por: Chow, Ariel Ka-Man, et al.
Publicado: (2020)

Fusion with stem cell makes the hepatocellular carcinoma cells similar to liver tumor-initiating cells
por: Wang, Ran, et al.
Publicado: (2016)

Deregulation of Frizzled Receptors in Hepatocellular Carcinoma
por: Chan, Kristy Kwan-Shuen, et al.
Publicado: (2018)

Road to stemness in hepatocellular carcinoma
por: Flores-Téllez, Teresita NJ, et al.
Publicado: (2017)

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2021)

Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection
por: Chan, Kelvin Yuen-Kwong, et al.
Publicado: (2011)

Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7uo0ma4fk59duaj3e68rpj4u6g